Journal
NATURE REVIEWS CANCER
Volume 3, Issue 7, Pages 517-525Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc1120
Keywords
-
Categories
Ask authors/readers for more resources
Most metastatic cancers are fatal. More than 80% of patients with metastatic testicular germ-cell tumours (TGCTs), however, can be cured using cisplatin-based combination chemotherapy. Why are TGCTs more sensitive to chemotherapeutics than most other tumour types? Answers to this question could lead to new treatments for metastatic cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available